[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352075-105":59,"doc-detail-352075-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","adam17-and-its-proteolytic-targets-in-disease-pathogenesis","ADAM17 and its proteolytic targets in disease pathogenesis","","ADAM17 (TACE) is a pleiotropic Zn2+-dependent metalloprotease of the ADAM family, with more than 90 substrates spanning growth factors, cytokines, receptors, and adhesion molecules. It regulates EGFR and TNF signaling pathways that link growth and inflammation, making ADAM17 a major therapeutic target in human cancers and inflammatory disorders. This review summarizes current knowledge on ADAM17 biology and how its proteolytic targets contribute to inflammation, cancer, and cardiovascular and metabolic diseases, highlighting key unresolved mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/adam17-and-its-proteolytic-targets-in-disease-pathogenesis/352075/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/adam17-and-its-proteolytic-targets-in-disease-pathogenesis/352075.png","ImageObject",300,407,{"name":92,"@type":93},"RuangKosong","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is ADAM17 (TACE) and why is it considered important in disease?","Question",{"text":112,"@type":113},"ADAM17 is an ADAM-family, Zn2+-dependent transmembrane metalloprotease that processes many substrates. It controls EGFR- and TNF-related signaling pathways that are crucial for growth and inflammation, linking it to cancers and inflammatory disorders.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling pathways does ADAM17 primarily regulate?",{"text":117,"@type":113},"The review highlights ADAM17 regulation of epidermal growth factor receptor (EGFR) signaling and tumor necrosis factor (TNF) signaling pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"How is ADAM17 activated and what role do iRhoms play?",{"text":121,"@type":113},"ADAM17 is synthesized in an inactive form and requires pseudoproteases iRhom1 or iRhom2. iRhoms help control trafficking and enable ADAM17 to become active, including processing of its inhibitory pro-domain in the Golgi.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352075,1790321673,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","MINI REVIEW  \nADAM17 and its proteolytic targets in disease pathogenesis Abdulbasit Amin 1,2 and Marina Badenes3,4,5   \n1 Gulbenkian Institute for Molecular Medicine (GIMM), Lisbon, Portugal  \n2 Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Nigeria  \n3 Veterinary Medicine Research (I-MVET), Faculty of Veterinary Medicine, Lusfona University – Lisbon University Center, Portugal  \n4 Veterinary and Animal Research Center (CECAV), Faculty of Veterinary Medicine, Lusfona University – Lisbon University Center, Portugal  \n5 Superior School of Health, Protection and Animal Welfare, Polytechnic Institute of Lusophony (IPLUSO), Lisbon, Portugal  \nKeywords  \nADAM17; cancer; cardiovascular diseases; inﬂammation; metabolic diseases  \nCorrespondence  \nM. Badenes, Universidade Lusfona, Centro Universitrio Lisboa, Campo Grande, 376 1749-024 Lisboa, Portugal  \nTel: 351217 515 500  \n[E-mail:](E-mail: marina.badenes@ulusofona.pt)[ marina.badenes@ulusofona.pt](E-mail: marina.badenes@ulusofona.pt)  \n(Received 28 May 2025, revised 29  \nDecember 2025, accepted 13 March 2026)  \ndoi:10.1111/febs.70516  \nADAM17, from the disintegrin and metalloproteinase (ADAM) family, also called tumor necrosis factor converting enzyme (TACE), is a pleiotropic protease with more than 90 substrates, including growth factors, cytokines, receptors, and adhesion molecules. The biology of ADAM17 has been extensively studied, mainly as a regulator of epidermal growth factor receptor (EGFR) and tumor necrosis factor (TNF) signaling pathways, which are crucial for growth and inﬂammation, respectively. Consequently, this protease has been considered a major target to treat human cancersand inﬂammatory disorders. Moreover, it is involved in the pathobiology of numerous other disease types. This review summarizes the current understanding of ADAM17 and the involvement of its targets in inﬂammation, cancer, and cardiovascular and metabolic diseases.  \nIntroduction  \nADAM17 (A Disintegrin and Metalloproteinase 17), also known as TACE, is a type-1 transmembrane metalloprotease belonging to the Zn2+ -dependent protease superfamily, which includes other ADAM (A Disintegrin and Metalloproteinase) family members [1,2] . ADAM17 is synthesized in the endoplasmic reticulum and undergoes complex post-translational maturation and regulation. It comprises several domains important for its biology (Fig. 1A) . Despite the numerous studies on ADAM17 biology, much remains to be known about the regulation  \nof ADAM17 activation, its substrate selectivity, and physiological functions. Several mechanisms governing ADAM17 maturation and function are well established, whereas others are emerging or still debated.  \nDuring biosynthesis, ADAM17 has an N-terminal signal peptide (1–17 residues) crucial for the protein translocation into the endoplasmic reticulum, being released afterwards. ADAM17 is synthesized as an inactive form, having a pro-domain that prevents premature ADAM17 activation by blocking the catalytic  \nAbbreviations  \nACE2, angiotensin-converting enzyme type 2; ADAM, 17 A Disintegrin and Metalloproteinase 17; ADAMs, A Disintegrin And Metalloproteinases; AKT, protein kinase B; Ang-II, Angiotensin II; APP, amyloid precursor protein; AREG, amphiregulin; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; FRMD, 8 FERM-domain containing 8; GH, growth hormone; HB-EGF, heparin-binding EGF-like growth factor; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; IL-6R, interleukin-6 receptor; iRhoms, rhomboid family of intramembrane pseudoproteases; iTAP, iRhom tail-associated protein; MAPK, mitogen-activated protein kinase; SEMA4B, Semaphorin 4B; STAT3, signal transducer and activator of transcription 3; TACE, TNF converting enzyme; TGF, transforming growth factor; TIMP-3, tissue inhibitor of metalloproteinase-3; TNF, tumor necrosis factor; TNFR, tumor necrosis factor receptor; VCAM-1, vascular cell adhesion molecule-1;","cbCaiguxdaDFDFgv","https://ap.wps.com/l/cbCaiguxdaDFDFgv","pdf",1394243,16,"English","# Introduction\n## ADAM17 biology and maturation\n## Regulation of ADAM17 activation and substrate selectivity\n## ADAM17 pathway overview\n## Abbreviations","[{\"question\":\"What is ADAM17 (TACE) and why is it considered important in disease?\",\"answer\":\"ADAM17 is an ADAM-family, Zn2+-dependent transmembrane metalloprotease that processes many substrates. It controls EGFR- and TNF-related signaling pathways that are crucial for growth and inflammation, linking it to cancers and inflammatory disorders.\"},{\"question\":\"Which signaling pathways does ADAM17 primarily regulate?\",\"answer\":\"The review highlights ADAM17 regulation of epidermal growth factor receptor (EGFR) signaling and tumor necrosis factor (TNF) signaling pathways.\"},{\"question\":\"How is ADAM17 activated and what role do iRhoms play?\",\"answer\":\"ADAM17 is synthesized in an inactive form and requires pseudoproteases iRhom1 or iRhom2. iRhoms help control trafficking and enable ADAM17 to become active, including processing of its inhibitory pro-domain in the Golgi.\"}]","ADAM17 and its proteolytic targets in disease pathogenesis | PDF",1790097568,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ba67fed6605101d35e953be4474dbc7.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad18958eda6c5a15fd136501dc52b786.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73a0b83b9c412d68d469e2cc8787754a.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c70148cd59b2c337d02ca76a4a5b349.webp",980,1287]